Biocryst Pharmaceuticals (BCRX) EPS (Basic) (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted EPS (Basic) of -$2.98 for Q1 2026, down 354.38% on a QoQ basis from $1.17 in Q4 2025, and down 1944998.8% year-over-year from N/an in Q1 2025.
Biocryst Pharmaceuticals (BCRX) EPS (Basic) (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$2.98 for Q1 2026.
- Quarterly EPS (Basic) fell 1944998.8% year-over-year to -$2.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.89 (down 638.52% YoY) and the FY2025 annual result came in at $1.26, up 392.35% from the prior year.
- EPS (Basic) was -$2.98 for Q1 2026 at Biocryst Pharmaceuticals, down from $1.17 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.17 in Q4 2025 and bottomed at -$2.98 in Q1 2026.
- A 5-year average of -$0.28 and a median of -$0.19 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2025 — EPS (Basic) soared 1003.53% — and 2026, when it plunged 1944998.8%.
- Biocryst Pharmaceuticals' EPS (Basic) stood at -$0.38 in 2022, then climbed by 16.54% to -$0.32 in 2023, then soared by 59.64% to -$0.13 in 2024, then surged by 1003.53% to $1.17 in 2025, then plunged by 354.38% to -$2.98 in 2026.
- Business Quant data shows BCRX's EPS (Basic) at -$2.98 in Q1 2026, $1.17 in Q4 2025, and $0.06 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.32 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | Biocryst Pharmaceuticals | 2.28 Bn | 2.21 Bn | 151.04 Mn | -2.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.98 |
| Dec 31, 2025 | 1.17 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.07 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.32 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -0.40 |
| Mar 31, 2023 | -0.28 |
| Dec 31, 2022 | -0.38 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -0.40 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.33 |
| Jun 30, 2021 | -0.24 |